187 related articles for article (PubMed ID: 11879801)
1. Selectivity of the protective effects of dihydropyridine calcium channel antagonists against the ethanol withdrawal syndrome.
Watson WP; Little HJ
Brain Res; 2002 Mar; 930(1-2):111-22. PubMed ID: 11879801
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel antagonists decrease the ethanol withdrawal syndrome.
Little HJ; Dolin SJ; Halsey MJ
Life Sci; 1986 Dec; 39(22):2059-65. PubMed ID: 3784769
[TBL] [Abstract][Full Text] [Related]
3. Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment.
Whittington MA; Dolin SJ; Patch TL; Siarey RJ; Butterworth AR; Little HJ
Br J Pharmacol; 1991 Jul; 103(3):1669-76. PubMed ID: 1834295
[TBL] [Abstract][Full Text] [Related]
4. The differential effects of felodipine and nitrendipine on cerebral dihydropyridine binding ex vivo and the ethanol withdrawal syndrome in mice.
Watson WP; Misra A; Cross AJ; Green AR; Little HJ
Br J Pharmacol; 1994 Aug; 112(4):1017-24. PubMed ID: 7524989
[TBL] [Abstract][Full Text] [Related]
5. Interactions between diltiazem and ethanol: differences from those seen with dihydropyridine calcium channel antagonists.
Watson WP; Little HJ
Psychopharmacology (Berl); 1994 Mar; 114(2):329-36. PubMed ID: 7838926
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D-,L-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines.
Palmer GC; Stagnitto ML; Ray RK; Knowles MA; Harvey R; Garske GE
Epilepsia; 1993; 34(2):372-80. PubMed ID: 7681002
[TBL] [Abstract][Full Text] [Related]
7. Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal; doses required, stereospecificity and actions of Bay K 8644.
Littleton JM; Little HJ; Whittington MA
Psychopharmacology (Berl); 1990; 100(3):387-92. PubMed ID: 1690434
[TBL] [Abstract][Full Text] [Related]
8. Dihydropyridine-sensitive calcium channels and barbiturate tolerance and withdrawal.
Rabbani M; Brown J; Butterworth AR; Little HJ
Pharmacol Biochem Behav; 1994 Mar; 47(3):675-80. PubMed ID: 8208788
[TBL] [Abstract][Full Text] [Related]
9. The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome.
Watson WP; Robinson E; Little HJ
Neuropharmacology; 1997 Oct; 36(10):1369-75. PubMed ID: 9423924
[TBL] [Abstract][Full Text] [Related]
10. Effects of dihydropyridines on the components of the ethanol withdrawal syndrome: possible evidence for involvement of potassium, as well as calcium?
Watson WP; Little JJ
Alcohol Clin Exp Res; 1997 May; 21(3):409-16. PubMed ID: 9161599
[TBL] [Abstract][Full Text] [Related]
11. Differing acute interactions of ethanol with two structurally related dihydropyridines, nitrendipine and felodipine.
Watson WP; Homewood N; Little HJ
Brain Res Bull; 1998 Nov; 47(4):337-43. PubMed ID: 9886785
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of drugs on hyperexcitability induced in hippocampal slices by withdrawal from chronic ethanol consumption.
Bailey CP; Molleman A; Little HJ
Br J Pharmacol; 1998 Jan; 123(2):215-22. PubMed ID: 9489608
[TBL] [Abstract][Full Text] [Related]
13. Effects of the calcium antagonists verapamil and nitrendipine on carbamazepine withdrawal.
Lazarova M; Petkova B; Staneva-Stoycheva D
Methods Find Exp Clin Pharmacol; 1999 Dec; 21(10):669-71. PubMed ID: 10702963
[TBL] [Abstract][Full Text] [Related]
14. Action of chlormethiazole in a model of ethanol withdrawal.
Green AR; Davies EM; Little HJ; Whittington MA; Cross AJ
Psychopharmacology (Berl); 1990; 102(2):239-42. PubMed ID: 2177205
[TBL] [Abstract][Full Text] [Related]
15. Correlation between increases in dihydropyridine binding in vivo and behavioural signs of ethanol withdrawal in mice.
Watson WP; Little HJ
Alcohol Alcohol; 1999; 34(1):35-42. PubMed ID: 10075399
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures.
Kotlinska J; Liljequist S
Psychopharmacology (Berl); 1996 Oct; 127(3):238-44. PubMed ID: 8912402
[TBL] [Abstract][Full Text] [Related]
17. Influence of hormonal status on behavioral responses to an acute ethanol challenge during ethanol withdrawal in male and female rats.
Koirala B; Alele PE; Devaud LL
Pharmacol Biochem Behav; 2008 Oct; 90(4):691-700. PubMed ID: 18603287
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice.
Zapater P; Javaloy J; Román JF; Vidal MT; Horga JF
Brain Res; 1998 Jun; 796(1-2):311-4. PubMed ID: 9689485
[TBL] [Abstract][Full Text] [Related]
19. The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice.
Verleye M; Heulard I; Gillardin JM
Alcohol; 2009 May; 43(3):197-206. PubMed ID: 19393860
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel antagonists prevent adaptive responses to ethanol.
Little HJ; Dolin SJ; Whittington MA
Alcohol Alcohol Suppl; 1993; 2():263-7. PubMed ID: 7748308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
